Loss of Ecrg4 improves calcium oxalate nephropathy.
Kidney stone is one of the most frequent urinary tract diseases, affecting 10% of the population and displaying a high recurrence rate. Kidney stones are the result of salt supersaturation, including calcium and oxalate. We have previously identified Esophageal cancer-related gene 4 (Ecrg4) as being...
Main Authors: | Daniela Cabuzu, Suresh K Ramakrishnan, Matthias B Moor, Dusan Harmacek, Muriel Auberson, Fanny Durussel, Olivier Bonny |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0275972 |
Similar Items
-
Loss of Ecrg4 improves calcium oxalate nephropathy
by: Daniela Cabuzu, et al.
Published: (2022-01-01) -
Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
by: Anna Kletzmayr, et al.
Published: (2020-04-01) -
ECRG-4 expression in normal and neoplastic choroid plexus
by: Gonzalez Ana, et al.
Published: (2010-12-01) -
A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma
by: Zhou Yun, et al.
Published: (2011-02-01) -
Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury
by: Daorina Bao, et al.
Published: (2023-07-01)